Cogan’s syndrome (CS) is a rare autoimmune disorder. It is a combination of vertigo, inflammation, and hearing loss. It generally affects the inner ears and eyes. Generally, 10% to 15% of people affected with Cogan’s syndrome experience vessel vasculitis inflammation. A research study in the Orphanet journal indicated that systemic manifestations may occur in more than 70% patients with the syndrome. Proximal aorta inflammation occurs in 10% of patients.

Cogan’s syndrome can affect a person of any age and race. It most frequently occurs in young adults in their late 20s or early 30s. The exact cause of Cogan’s syndrome is unknown. It is quite difficult to say that Cogan’s syndrome is cause by an autoimmune response that is responsible for an attack on the tissues of the eyes and ears. Most common sign and symptomless associated with Cogan’s syndrome are eyes redness, excessive tear production, irritation and pain, photophobia (sensitivity to light), tinnitus (ringing in the ears), sensorineural hearing loss, dizziness, and decreased vision. Ophthalmologists diagnose the swelling of specific tissues of the eyes for Cogan’s syndrome. Others disease such as Meniere disease, syphilis, Epstein-Barr virus, and Lyme disease have similar signs and symptoms. Doctors also recommended blood tests for a specific antibody to diagnose Cogan’s syndrome in some cases.

Health care professionals primarily observe the symptoms associated with Cogan’s syndrome. Based on symptoms, doctors or health care professionals recommended treatment. Corticosteroids or immunosuppressive agents are used as medications for the treatment of Cogan’s syndrome. In some cases, medication is not effective, and the syndrome can progress quickly. In these cases, the syndrome can lead to permanent hearing or vision loss. The percentage of permanent hearing loss is higher compared to that of permanent vision loss.

Major factors driving the Cogan’s syndrome market include a rise in the geriatric population and increase in awareness about the disease and treatment.

The Cogan's syndrome market can be segmented based on treatment, end-user, and region. Based on treatment, the Cogan's syndrome market can be categorized into medications and surgery. Corticosteroids and immunosuppressive agents are common medications for Cogan's syndrome. Immunosuppressive agents such as cyclophosphamide, cyclosporine, methotrexate, infliximab, and azathioprine are preferred for treatment.  The surgical process is reserved for patients who are unresponsive to medication.

In terms of end-user, the global Cogan's syndrome market can be segmented into hospitals, specialized clinics, and others. In terms of revenue, the hospitals segment held a significant share of the Cogan's syndrome market in 2017.

Based on region, the global Cogan's syndrome market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a significant share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a major share of the market in North America in terms of revenue in 2017. The market in Asia Pacific is expanding rapidly due to an increase in the number of patients. Moreover, Asia Pacific is projected to be a highly attractive region of the cogan’s syndrome market in the near future. This is due to the presence of emerging economies such as India, China, and Japan. Furthermore, factors such as better health care infrastructure, economic growth, and rise in the number of insurance payers, expanding and developing private health care sector, and increase in disease awareness among people are expected to propel the market in the region.

Key players operating in the global Cogan's syndrome market include Mylan N.V., Sun Pharma Global Inc., Zydus Pharmaceuticals (USA) Inc., Pfizer Inc., Amerigen Pharmaceuticals Limited, Johnson & Johnson Services, Inc. Wockhardt Limited, Teva Pharmaceutical Industries Ltd, and AbbVie Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Cogans Syndrome Market

Pre Book